Pharmacogenomics of drug efficacy in the interferon treatment of chronic hepatitis C using classification algorithms
{{output}}
Chronic hepatitis C (CHC) patients often stop pursuing interferon-alfa and ribavirin (IFN-alfa/RBV) treatment because of the high cost and associated adverse effects. It is highly desirable, both clinically and economically, to establish tools to distinguish r... ...
